| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||
Net loss | ||||||
-1,317 | 2,595 | |||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Interest income held in Trust Account | ||||||
4,108 | 3,081 | |||||
Changes in operating assets and liabilities: | ||||||
Prepaid expenses | ||||||
-104 | 143 | |||||
Accounts payable | ||||||
1,579 | 0 | |||||
Accrued expenses | ||||||
2,860 | 0 | |||||
Accrued expenses - related party | ||||||
-55 | 105 | |||||
Due to related party | ||||||
386 | - | |||||
Net cash used in operating activities | ||||||
-549 | -524 | |||||
Proceeds deposited in Trust Account | ||||||
- | 200,000 | |||||
Net cash provided by investing activities | ||||||
- | -200,000 | |||||
Funds borrowed from related parties | ||||||
- | 170 | |||||
Repayment of loans to related parties | ||||||
- | 325 | |||||
Proceeds received from initial public offering, gross | ||||||
- | 200,000 | |||||
Offering costs paid | ||||||
- | 4,882 | |||||
Proceeds received from private placement | ||||||
- | 6,000 | |||||
Net cash used in financing activities | ||||||
- | 200,962 | |||||
Net decrease in cash | ||||||
-549 | 437 | |||||
Supplemental disclosure of noncash investing and financing activities: | ||||||
Deferred underwriting commissions charged to equity in connection with the initial public offering | ||||||
- | 7,000 | |||||
Deferred offering costs charged to equity upon completion of the initial public offering | ||||||
- | 276 | |||||
Class A Ordinary Shares [Member] | ||||||
Initial value of Class A ordinary shares subject to possible redemption | ||||||
- | 189,101 | |||||
Decrease in value of Class A ordinary shares subject to possible redemption | ||||||
-1,317 | 2,564 | |||||